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Abstract
Background: Induced and spontaneous sputum are used to evaluate the airways microbiota. Whether the sputum
types can be used interchangeably in microbiota research is unknown. Our aim was to compare microbiota in
induced and spontaneous sputum from COPD patients sampled during the same consultation.
Methods: COPD patients from Bergen, Norway, were followed between 2006/2010, examined during the stable
state and exacerbations. 30 patients delivered 36 sample pairs. DNA was extracted by enzymatic and mechanical
lysis methods. The V3-V4 region of the 16S rRNA gene was PCR-amplified and prepared for paired-end sequencing.
Illumina Miseq System was used for sequencing, and Quantitative Insights Into Microbial Ecology (QIIME) and Stata
were used for bioinformatics and statistical analyses.
Results: Approximately 4 million sequences were sorted into 1004 different OTUs and further assigned to 106 different
taxa. Pair-wise comparison of both taxonomic composition and beta-diversity revealed significant differences in one or
both parameters in 1/3 of sample pairs. Alpha-diversity did not differ. Comparing abundances for each taxa identified,
showed statistically significant differences between the mean abundances in induced versus spontaneous samples for
15 taxa when disease state was considered. This included potential pathogens like Haemophilus and Moraxella.
Conclusion: When studying microbiota in sputum samples one should take into consideration how samples are
collected and avoid the usage of both induced and spontaneous sputum in the same study.
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Background
Chronic obstructive pulmonary disease (COPD) is char-
acterized by a chronic inflammation of the lower air-
ways, dominated by an influx of innate immune cells.
Recent marker-gene studies indicate the existence of a
pulmonary microbial flora (microbiota) present in both
health and disease [1]. The chronic inflammation seen in
COPD might be a consequence of a disrupted equilib-
rium between the pulmonary microbiota and the innate
immune system. To explore this hypothesis, accurate
measurements of the microbiota during both stable state
and acute exacerbation of chronic obstructive pulmon-
ary disease (AECOPD) are necessary.
The emerging gold standard for exploring the micro-
biota in the lower airways with minimal oral contamin-
ation is through bronchoscopy, but this is impossible
during most AECOPD. Collecting induced sputum sam-
ples (ISS) is therefore a standardized sampling method
of choice [2]. However, in several studies spontaneous
sputum samples (SSS) have also been used since they are
easier to retrieve [3, 4]. The validity of SSS with regard
to microbiota studies is uncertain to date. Two previous
studies have compared the microbial composition in ISS
and SSS samples from cystic fibrosis (CF) patients, find-
ing comparable results between the two methods [5, 6].
However, CF patients usually produce more sputum
spontaneously, have a relatively high biomass in the
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airways, and one of the cited studies used an earlier
method of bacterial profiling (Terminal Restriction Frag-
ment Length Polymorphism Profiling) [6], wheras the
other had only 15 sputum pairs [5]. The validity of SSS
with regard to 16S rRNA marker-gene based studies on
non-CF patients is unknown to date.
The Bergen COPD Cohort Study (BCCS) and its
adjunct Bergen COPD Exacerbation Study (BCES) offers
an opportunity to address this issue in COPD patients as
we have sampled sputum both induced and spontan-
eously in a number of our COPD patients repeatedly
during follow-up. We have previously shown that levels
of inflammatory markers differed between sputum types
in a study from the same population [7]. In the present
study we compared the taxonomic composition and
diversity measures in 36 sputum pairs consisting of SSS
and ISS sampled sequencially from COPD patients
either during AECOPD or at the stable state.
Methods
Study design
The current study sample consisted of 36 sputum pairs col-
lected from 30 COPD patients who participated in both the
BCCS & BCES. The study design and sampling of the
BCCS [8] and the BCES [7] has previously been described
in detail. The COPD patients had a smoking history of ≥10
pack-years, and a post-bronchodilation FEV1/FVC ratio < 0.7
and FEV1 < 80% predicted. Active autoimmune diseases or
cancer within the last 5 years were cause for non-inclusion.
A study physician examined and undertook a structured
interview of all patients upon inclusion and at half-yearly
follow-up visits when the patients were in the stable state.
Patients were instructed to contact the study-staff at
periods with worsening of symptoms (malaise, fever,
airway symptoms). The study physician offered a clinical
examination at the outpatient clinic, Dept. of Thoracic
Medicine, Haukeland University Hospital within 24 h of
contact, or on the first working day after the weekend.
Hospitalized patients were examined by a study
physician the first day after admission.
The study was approved by the regional ethical board
(REK-Vest), case number 165.08.
Sputum sampling and processing
Both sputum sampling and immediate processing have
been described in detail [7]. SSS was collected first from
patients expectorating. If the patient’s clinical state allowed
it, induction with hypertonic saline (3%) was performed.
Patients inhaled the saline for 7 min three times, and
sputum was collected and pooled after each inhalation.
Spirometric evaluations were performed before and after
each inhalation during induction (Vitalograph S-model
Vitalograph Ltd., Buckingham, England at regular visits in
the steady state, EasyOne model 2001 Ndd Medizintechnik
AG, Zurich, Switzerland at exacerbation visits). Sputum
samples were kept on ice until undergoing quality control
less than 30 min after sampling. For the sputum samples
to be considered of acceptable quality there had to be >1
million/mL cells, <20% epithelial cells and the leucocyte
viability had to be >30%. If the samples were of sufficient
quality, they were further treated by standard protocol [7]
to separate the supernatant from the cell pellet. All mate-
rials were aliqouted and frozen at −80 °C.
DNA extraction and 16S rRNA sequencing
The samples were thawed and treated with sputasol
(Oxoid). They underwent pre-lysis with Lysostaphin
(4000 U/mL), Lysozyme (10 mg/mL) and Mutanolysin
(25,000 U/mL) (Sigma-Aldrich). To avoid shearing of
free DNA each sample was centrifuged and supernatants
and pellets separated. The pellets underwent mechanical
and chemical lysis using the FastPrep-24 Instrument and
reagents from the FastDNA Spin Kit (MP Biomedicals,
LLC, Solon, OH, USA). Lysates and supernatants from
each sample were recombined and the extracted DNA
was further purified using the FastDNA Spin Kit. Library
preparation and sequencing of the V3-V4 region of the
16S rRNA gene was carried out according to the proto-
col for Metagenomic Sequencing Library Preparation for
the Illumina Miseq System (Part # 15044223 Rev. B,
MiSeq Reagent Kit v3). Amplicon PCR was carried out
with a total of 45 cycles and followed by Index PCR
using primers from the Nextera XT Index Kit (Illumina
Inc., San Diego. CA, USA). Pooled, normalized samples
went through 2 × 300 cycles of paired-end sequencing.
Each of the sample pairs were processed on the same
day, and for all pairs we used the same reagent kits
throughout DNA extraction, PCR and sequencing.
Bioinformatics analyses
FASTQ-files were computed using Quantitative Insights
Into Microbial Ecology (QIIME) v.1.9.1 [9, 10]. First,
forward and reverse reads were assembled, after which
sequences that did not pass quality demands as advised
by QIIME were removed [11]. The accepted sequences
were clustered into operational taxonomic units (OTUs)
through open reference OTU-picking using uclust
v.1.2.22 [12] and the GreenGenes Database v.13_08 [13].
The latter was also used for taxonomic assignment with
analyses performed on GreenGenes taxonomic level 6
(genus). The clustering was based on sequence similarity
with a threshold of 97%, which is considered the con-
ventional cut-off for 16S rRNA maker-gene surveys and
representative for bacterial species [14]. For each OTU a
representative sequence was aligned using PyNAST
v.1.2.2 [15], and sequences not successfully aligned were
omitted from further analyses. A phylogenetic tree was
built using FastTree v.2.1.3 [16]. Counts of observations
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(OTUs) on a per-sample basis were stored in Biological
Observation Matrix (BIOM) format and OTUs contain-
ing less than 0.005% of the total number of sequences
were removed according to QIIME guidelines [10, 11].
Statistical analyses
Comparisons of the taxonomic distribution between
pairs were performed both by calculating the Yue-
Clayton measure of dissimilarity (1-θYC - range 0 to 1; 0
indicates perfect similarity, 1 perfect dissimilarity) [17],
and using limits of agreement (LOA) calculated from
Bland-Altman plots [18, 19]. Both methods allow evalu-
ation of quantitative differences within each pair.
The mean number of sequences allocated to each identi-
fied taxa in the 36 ISS was compared to that found in the
36 SSS, using log-likelihood ratio tests with Bonferroni cor-
rected p-values due to multiple comparisons. The compari-
sons were made between samples normalized through
rarefaction with random subsampling without replacement.
Comparisons of alpha- and beta-diversity were performed
on rarefied OTU-tables [20] with available statistical
analyses incorporated in QIIME-scripts. Alpha-diversity
(within-sample diversity) was estimated using Faith’s phylo-
genetic diversity, Chao1 and counts of observed OTUs.
Beta-diversity is a measure of diversity between samples.
To evaluate differences in phylogenetic, quantitative beta-
diversity pair-wise, weighted UniFrac (WUF) significance
tests were applied [21]. All 72 samples were compared gen-
erating 2556 comparisons, for which Bonferroni corrected
p-values were used.
Principal coordinates analysis (PCoA)-plots of WUF
distances between sampling methods were used for
visualization of distances in three-dimensional space
using Procrustes analyses and transformations of prin-
cipal coordinates 1-3 [22]. Analyses of similarities
(ANOSIM), were used to compare differences in beta-
diversity between ISS and SSS when samples were
grouped by type [23], both considering WUF and its quali-
tative equivalent unweighted UniFrac distances (UWUF).
Stata 13.1 (StataCorp LP. 2013. College Station, TX)
was used for generation of the Bland-Altman plots.
All relevant data were deposited at the Dryad Digital
Repository (www.datadryad.org) and are referenced in
the text using the following doi: http://dx.doi.org/
10.5061/dryad.5gc82.
Results
We obtained a total of 36 high-quality pairs of spu-
tum from 30 different COPD patients. Eleven patients
were women; two thirds of patients were aged 55-
64 years at inclusion. Patient characteristics are
summarized in Table 1.
After processing of the raw data, 1004 different OTUs
were identified with 2.5 of 4 million sequences belonging
to samples delivered at exacerbations (25 of the 36
sputum pairs).
Taxonomy
The 1004 OTUs identified by QIIME were sorted into
106 different taxa by QIIME’s taxonomic summary
command. First, we calculated the Yue-Clayton measure
of dissimilarity between the mean abundances of the
most dominating OTUs (each containing ≥1% of all
sequences) assigned to 11 different taxa in all ISS versus
all SSS. This represents a group comparison and not a
pair by pair comparison. The samples were then sorted
with regards to disease state at time of sampling. The
dissimilarity (1-θYC) measure was 0.04 when disease
state was not considered. For exacerbation samples the
dissimilarity (1-θYC) measure was also 0.04, and for
stable state samples 0.03. Performing the same analyses
including also low-abundance OTUs gave a dissimilarity
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(1-θYC) measure of 0.04 when all samples were included,
and 1-θYC of 0.04, and 0.05 for exacerbation and stable
samples respectively.
Taxonomic compositional differences within sample
pairs were visualized as bar graphs for the same 11 dom-
inating taxa (Fig. 1). As shown, there were obvious visual
differences within some pairs. 1-θYC was calculated both
for dominating OTUs exclusively, and for all OTUs.
When evaluating dissimilarities pair-wise for dominating
OTUs and their associated taxa, 1-θYC ranged from
<0.01 – 0.92 (Fig. 1). 1-θYC ranged from <0.01 – 0.58
when also including sparse OTUs and corresponding
taxa (data not shown). With 0.2 as limit for acceptable
within-pair 1-θYC, seven pairs were found dissimilar
regardless of OTU-abundance (pairs 8, 11, 19, 20, 27, 34
and 36), while four pairs were found dissimilar only if
filtering out low-abundance OTUs (pairs 6, 14, 24 and
28) or keeping low-abundance OTUs respectively (pairs
3, 13, 22 and 26).
To further assess differences in taxonomy between
sample pairs, one Bland-Altman plot of the relative
abundances of our 106 taxa was generated for each pair.
From the upper and lower 95% LOA, the range is calcu-
lated (upper-lower/100) corresponding to a number
between 0 and 1, where 0 indicates perfect agreement.
Using this approach, we found ranges in LOA between
Fig. 1 Compositional taxonomic differences for each sample pair** on genus level for the 11 most dominating taxa***. * Yue-Clayton dissimilarity = Range
0-1. **Pair 1-11: Stable state Pair 12-36: Exacerbation. ***OTUs containing <1% of sequences were omitted from the data before performing taxonomic
summaries (GreenGenes database level 6 = genus)
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0.02-0.66 (Fig. 2). Setting an acceptable limit for LOA at
0.1 allows the relative abundance in each taxa to vary
from ISS to SSS by 10%. With this limit 13 pairs could
not be accepted as equal, including the seven pairs
found too different by 1-θYC regardless of OTU-
abundance (Fig. 2).
There were significant differences between the mean
abundances in induced versus spontaneous samples for 15
taxa in either the exacerbated or the stable state (Table 2).
For instance for the well known pathogenic Moraxella,
there were almost twice as many sequences in all spontan-
eous samples compared with all the induced samples both
during exacerbations and in the stable state (p < 0.001,
Table 2). Also Haemophilus was consistently more abun-
dant in spontaneous than in induced samples.
Diversity
No statistically significant differences were found in
alpha-diversity (Table 3).
However, we found statistically significant differences
(p < 0.01, Bonferroni corrected due to multiple compari-
sons) in the pair-wise quantitative, phylogenetic beta-
diversity as evaluated by weighted UniFrac for 9 pairs
(Pair 3, 14, 17, 19, 26, 30, 32, 33 and 36).
The principal coordinates analysis (PCoA) plots are
presented in Fig. 3.
Each dot represents the weighted UniFrac distance
diversity measure for each sample, and lines illustrating
the distance between paired sputum are shown (Blue
line attaches to ISS, red to SSS). The greater the
distance, the greater is the difference. Although this is a
two-dimensional visualization of a three-dimensional
calculation, Fig. 3 clearly shows that the distances be-
tween paired samples varied. A Monte Carlo simulation
with 1000 permutations was applied giving M2 = 0.5,
confirming the visual interpretation (Identical plots:
M2 = 0, if completely dissimilar M2 = 1).
Using analyses of similarities (ANOSIM), we found no
significant differences in means of beta-diversity (UWUF
and WUF) between ISS and SSS when samples were
grouped by type. This was true both in stable state and
at exacerbations (p > 0.05).
Discussion
This study on sputum samples collected sequentially
using two different methodologies from COPD patients
and treated equally by the same protocol shows that in
approximately 1/3 of sputum pairs either taxonomical
and/or diversity analyses differ significantly. Discordance
between induced and spontaneous samples were seen
both at exacerbations and during stable state.
The strength of the current study is the unique data
material; including induced and spontaneous sputum
samples collected simultaneously, treated by the same
protocol [7, 8], both at the stable state and during exac-
erbations. However, there are some methodological
issues to discuss. First, after either induction or through
sampling of spontaneous sputum, sputum was kept in a
clean collection dish, and material selected by trained
technicians for further analyses. This is the standard
approach [24], but entails a natural variation of sample
selection. However, there is no reason to believe the
judgment of the technician should differ between sample
types, and all other processing was the same for both
types of sputum.
Second, errors may occur during DNA extraction,
PCR or sequencing steps. All pairs were run simultan-
eously for all steps in the laboratory protocol, including
Fig. 2 Expected differences between relative abundances of taxa per sample pair with 95% Bland-Altman limits of agreement. *Range = 0-1.
**Pair 1-11: Stable state Pair 12-36: Exacerbation
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on the same flowcell in the Illumina MiSeq. However,
random errors could be a factor, and based on the plots
of the dominant taxa in Fig. 1, we chose the seven most
visually dissimilar pairs (pairs 11, 14, 19, 20, 26, 27 and
36) and three visually similar pairs (pairs 2, 5 and 29)
and redid the laboratory analyses. For only one of the 20
samples (pair 26, ISS) were the results convincingly
different visually from the first to the second run. Since
this was not a random selection, the likely error is much
lower than 5%, and we do not believe our results are
due to random laboratory error. For data analyses we
chose to keep the sequences from run two for the ten
re-run pairs.
Third, low biomass samples are prone to contamin-
ation from multiple sources during laboratory handling
[25]. Approaches to handle the potential contamination
include sequencing of known (“mock”) communities,
negative control samples, and manual curation of the
sequencing output. A potential contaminator in our
study is the saline used for induction. Unfortunately it
was not stored at the time the procedures were
performed, and so an important limitation to the current
study is that we were not been able to examine the influ-
ence of negative saline controls on our samples. All sam-
ples were treated exactly similar at all steps of analyses,
thus minimizing confounding from potential contamin-
ation. However, as the biomass and dilution of each
sample in a pair may differ, we cannot exclude that
samples could be differentially affected by contamination
from saline. Finally, as in other studies comparing
Table 2 Mean number of sequences per sample constituting the 15 taxaa found in significantly different amounts in induced and
spontaneous sputum from COPD patients with and without respect to disease state
All samples Exacerbation Stable state
Taxonomyb Induced Spontaneous pc Induced Spontaneous pc Induced Spontaneous pc
f_Prevotellaceae;g_Prevotella 2499.2 1760.3 <0.001 2633.1 1817.1 <0.001 2349.5 1763.0 <0.001
f_Pasteurellaceae;g_Haemophilus 1471.9 2440.3 <0.001 1308.2 2356.6 <0.001 1957.7 2859.8 <0.001
f_Moraxellaceae;g_Moraxella 259.2 542.3 <0.001 234.4 456.5 <0.001 353.9 798.0 0.001
f_Veillonellaceae;g_Veillonella 1488.3 1170.8 <0.001 1618.8 1173.1 <0.001
f_Veillonellaceae;g_Megasphaera 179.9 100.0 <0.001 201.9 111.5 <0.001 134.8 79.4 0.01
f_Corynebacteriaceae;g_
Corynebacterium
44.9 12.0 <0.001 60.3 14.9 <0.001
f_Oxalobacteraceae;g_Ralstonia 423.3 604.7 <0.001 331.8 213.3 <0.001
f_Comamonadaceae;g_Curvibacter 518.7 713.0 <0.001 430.7 269.5 <0.001
f_Leptotrichiaceae;g_Leptotrichia 171.8 95.2 <0.001
f_Neisseriaceae;g_Neisseria 344.5 149.8 <0.001
f_Gemellaceae;g_Gemella 84.9 16.5 <0.001
f_Gemellaceae;g_ 452.7 273.6 <0.001
f_Neisseriaceae;g_ 79.5 17.5 <0.001
f_Leptotrichiaceae;g_Leptotrichia 123.6 217.6 <0.001
f_Actinomycetaceae;g_Actinomyces 350.1 256.0 0.001
aRarefied OTU-tables: Sequences/Sample = 18,250 for All samples and Exacerbations, for Stable state: 19,743
bGreenGenes Level 6: f_ = Name of family level g_ = Name of genus level. One hundred six different taxa in total
clog-likelihood ratio test, Bonferroni corrected due to multiple comparisons
Table 3 Mean within sample diversity (alpha diversity) in induced versus spontaneous sputum in COPD by different alpha diversity
indices
All samples Exacerbation Stable state
Diversity Indices Induced Spontaneous pa Induced Spontaneous pa Induced Spontaneous pa
Faith’s Phylogenetic Diversity
mean (std) 56.9 (9.3) 56.2 (8.6) 0.7 57.3 (9.5) 56.2 (8.8) 0.7 57.1 (8.5) 56.6 (8.4) 0.9
Chao1
mean (std) 646.5 (116) 638.3 (107.5) 0.7 655.0 (118.5) 642.1 (105.1) 0.7 640.8 (110.4) 643.6 (105.3) 0.9
Observed OTUs
mean (std) 543.2 (104.9) 528.8 (106.1) 0.6 552.9 (105) 534.3 (107.1) 0.6 531.6 (102.4) 527.7 (103.2) 0.9
aNon-parametric two-sample t-test using Monte Carlo permutations
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sampling methods’ impact on microbiota [5, 26, 27], the
number of samples is limited, and the statistical power
therefore reduced.
One of the challenges in microbiome research is
that the technological advancements develop faster
than the establishment of statistical tools to assess
results. What signifies a true compositional difference
between two supposedly similar samples where each
contains a large number of relative abundances of
sequences is still an unsettled question. The cut-off
for the two indices used for assessment of taxonomic
differences, <0.2 for the Yue-Clayton dissimilarity
index (1-θYC) and <0.1 for LOA from the Bland
Altman plots, are arbitrary, and no established con-
sensus regarding these values exist. Similar for the
Procrustes M2 value there are no defined limit [28].
Finally, what constitutes a true clinically important
difference is also an unsettled question. It could be that
the entire ecological content of a sample is more relevant
for disease, or it could be the presence of a few, perhaps
even only one, low-abundant pathogen. If the latter is true,
a cut off <0.2 for 1-θYC and <0.1 for LOA will be too
crude. With a sample size of 36 sputum pairs, this study
did not have the power to evaluate whether ISS or SSS
better correlated with clinical data. Future studies with lar-
ger sample sizes are needed to elucidate this question.
This study brings forward new information on the
much used sputum samples in studies on COPD pa-
tients. Pair-wise comparisons of taxonomic composition
on genus-level between ISS and SSS from lung patients
have not previously been done to our knowledge.
Neither have comparisons of alpha- or beta-diversity
between ISS and SSS earlier been reported. Induced
sputum sampling is an established protocol for studying
COPD patients at stable state [29]. Common for both
ISS and SSS is that they sample both lungs in contrast
to bronchoalveolar lavage and biopsies, and are more
easily accessible material. Spontaneous sputum is easier
to collect during AECOPD when sputum production
increase, and may be preferred by some for fear that
induction may worsen airway obstruction. However, we
have previously shown that induction can safely be
performed during COPD exacerbations, at least with up
to 3% hypertonic saline [7].
There are potential reasons why spontaneous and
induced sputum samples would differ in their microbial
content. Different airways regions have been shown to
harbor different communities [30, 31], possibly partly
due to different ventilation-circulation ratios in the
lower and upper parts of the lungs, and possibly due to
differences between proximal and distal airways. It has
been shown before that sputum sampled early during
induction has a different composition of cells than spu-
tum sampled late during induction [32, 33]. Spontaneous
samples may resemble proximal airways more than the
distal sampled by induction, and possible differ in ability
to sample upper and lower airways.
Abundant OTUs and correspondingly dominating
taxa in different environments have been shown to be
particularly important in their habitats [34]. However,
sparse members of the microbiota have also been
found to contribute in pathogenic processes in the
lungs [35, 36]. With this in mind we chose to exam-
ine the identified taxa emphasizing both dominating
and sparse OTUs. The group comparison of mean
abundances of taxa by Yue-Clayton dissimilarity
showed that pooling of observations can hide differ-
ences seen between individual sample pairs.
The strength of the 1-θYC index is that it measures
structural dissimilarity by calculating the proportions of
both shared and unshared components in a community
[17]. The number of pairs where ISS and SSS were con-
sidered too dissimilar to be accepted as good substitutes
for each other (1-θYC > 0.2) was the same regardless of
focusing on taxonomic assignment of only abundant
OTUs or accepting all OTUs. In both cases 1 of 3 pairs
would render different results depending on which sam-
ple type was picked to represent the patient.
The Bland-Altman’s LOA analyses confirmed the find-
ings using Yue-Clayton’s dissimilarity, in that ISS and
SSS did not provide the same results in a significant
fraction (13 of 36) of pairs when evaluating taxonomical
composition in sputum from COPD patients.
Summarizing our findings on GreenGenes genus-
level left 106 unique taxa. When comparing the mean
abundance of sequences in each taxa between sample
types, 8.5% of taxa were found in statistically signifi-
cant different levels between sputum types during
Fig. 3 PCoA plots modeling multi-dimentional distribution of OTUs
derived from induced and spontaneous sputum samples*. *Sample
pairs connected by bars - blue bars attach to induced sputum samples,
red bars attach to spontaneous sputum samples
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exacerbations, and 11.3% in the stable state. Both of
the known potential pathogens Haemophilus and
Moraxella were significantly more abundant in spon-
taneous samples compared with induced samples,
both in the stable state and during exacerbations. In
this new era, where the whole composition of a
microbiome may be relevant for disease, it may be
that induced sputum samples better reflect presence
of low-abundant species in the distal airways, which
are masked by frequent colonization of genera like
Haemophilus and Moraxella in spontaneous samples.
However, presence of both Haemophilus [37, 38] and
Moraxella [39] in stable state sputum samples have shown
similar higher levels of inflammatory markers in the spu-
tum samples indicating stimulation of the immune system.
Thus either sampling method may have important value
in research, but important differences in interpretation of
the microbiota could result from using the sputum types
interchangeably.
We could not find differences in alpha-diversity be-
tween sample types. This should perhaps not be surpris-
ing considering the shared route of delivery through the
oral cavity and the samples not discriminating between
right and left airways. It has been shown that diversity in
sputum is higher than in explant lung samples, likely
due to oral contamination [30].
There were no significant differences in mean phylo-
genetic beta-diversity between ISS and SSS, neither
when considering absence/presence data, nor when
emphasizing abundances (UWUF/WUF). However,
when considering samples pair-wise we found differ-
ences in WUF in 1 of 4 pairs and for UWUF differences
were found in 50% of the sputum pairs. With focus on
quantitative data Procrustes transformation of PCoA-
plots of WUF distances this pair-wise difference was
confirmed, as the distances in multidimensional space
were too large to ignore for several pairs. A defined limit
for Procrustes M2 to be considered too high to claim
similarity does not exist, but levels >0.3 is indicative of
influential differences.
Conclusions
In this study we found clear discrepancies in both
taxonomic composition and beta-diversity between
ISS and SSS collected concurrently from COPD
patients in the stable state and during exacerbations
when comparing samples pair-wise. For grouped ana-
lyses the differences were subtler, potentially masking
important differences. The most prudent approach in
studies using sputum for microbiota analyses is to
only rely on either induced or spontaneous sputum.
We advise that sampling method is always reported,
and that comparisons are made and presented, if both
sample types are used.
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